Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection.
about
A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse modelRibavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysisEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverRecent advances in research on Crimean-Congo hemorrhagic fever.Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse modelLethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever.Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatmentAnimal models of tick-borne hemorrhagic Fever viruses.A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systemsCurrent treatment of Crimean-Congo hemorrhagic fever in children.Crimean-Congo hemorrhagic fever: an overview.Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin.Recent progress in the treatment of Crimean–Congo hemorrhagic fever and future perspectives
P2860
Q24276422-1F1FBDB6-C166-4259-A525-53A80919ACC1Q24599685-7B5ED3B7-16D8-4501-B449-4CF4508A84A4Q27457152-5D4BC8F3-0F7F-4053-91FC-BC6CC08871D8Q30205763-C6E0E6C2-C5D0-4C19-BE1C-4299FDE8B720Q33391592-3CACDF57-E89D-4949-B6FB-906C171337E7Q33405943-1573712A-2271-4916-A10C-A98C1F66B9A9Q33558533-D89C3505-A905-483F-944D-7B00F44C9B56Q34048367-277A3588-4217-4369-8F8C-F216B2F0FF22Q34094867-3BA3DD7C-EF89-4969-8C56-6A31C4585C27Q34533620-9AB0D09B-CF1C-4680-8E73-BCF6FDD8B51CQ34996107-D264739A-09AB-4B7A-9D0B-AB8C7D24FE5EQ37778828-883F7F44-20B7-464F-8C5C-B3DFED6B7DCEQ38126427-0A2EF1AB-A109-4E7D-BC6D-E518C743BEE2Q39539133-8F4D64F5-8F8A-40C3-9604-BDB489550AD8Q56776119-C6487E74-A9C5-4AB7-9F28-0DC963D6F63A
P2860
Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Ribavirin efficacy in an in vi ...... fever virus (CCHF) infection.
@en
type
label
Ribavirin efficacy in an in vi ...... fever virus (CCHF) infection.
@en
prefLabel
Ribavirin efficacy in an in vi ...... fever virus (CCHF) infection.
@en
P1433
P1476
Ribavirin efficacy in an in vi ...... fever virus (CCHF) infection.
@en
P2093
P304
P356
10.1016/0166-3542(93)90040-P
P577
1993-12-01T00:00:00Z